Andrew Lawrence Taylor is CFO at Orchestra BioMed Holdings, Inc. (OBIO). They have made 6 open-market trades across 2 companies since 2018, most recently 2026-08-26.
CIK 0001723889
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $25K since 2018, never a sale. Across 6 scored buys the stock is up 20.4% at ninety days, and 18.0 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 67% | 67% | 67% |
| Avg Move | +8.5% | +8.9% | +20.4% |
| Alpha | +7.7% | +6.6% | +18.0% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OBIO | BUY | 2025-08-25 | 2025-08-25 | $2.55 | $5K | +3.4% | -9.0% | +82.0% |
| OBIO | BUY | 2024-12-19 | 2024-12-20 | $4.83 | $5K | +18.2% | +5.5% | -11.2% |
| MOTS | BUY | 2021-11-19 | 2021-11-22 | $0.51 | $1K | -14.1% | +0.0% | -28.4% |
| MOTS | BUY | 2020-12-09 | 2020-12-10 | $1.08 | $1K | -13.0% | -6.1% | +20.9% |
| MOTS | BUY | 2018-12-24 | 2018-12-26 | $2.70 | $3K | +42.5% | +53.6% | +47.9% |
| MOTS | BUY | 2018-02-16 | 2018-02-21 | $5.00 | $10K | +14.4% | +9.1% | +11.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.